Oracle named insiders Clay Magouyrk and Mike Sicilia as co-CEOs on Monday, replacing Safra Catz, who was at the helm of the ...

Oracle ( NYSE: ORCL) is working to borrow $15B from the U.S. investment-grade bond market, according to Bloomberg.

* If you open an account using links which have an asterisk, This is Money will earn an affiliate commission. We do not allow this to affect our editorial independence nor will it impact the interest ...

The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.